Our Instructors
Sessions are taught by successful healthcare innovators, subject-matter experts, and Innovation support staff. In-short – Mass General Brigham’s best.
Instructors
Radiologist-in-Chief, Mass General Hospital
James Brink, MD
Dr. Brink is Radiologist-in-Chief at the Massachusetts General Hospital (MGH) and the Juan M. Taveras Professor of Radiology at Harvard Medical School. Dr. Brink served as Chair of the Yale Department of Diagnostic Radiology from 2006 to 2013 prior to returning to MGH as Radiologist-in-Chief.
Director of Research Strategy & Operations at the MGH & BWH CCDS
Kathy Andriole, PhD
Dr. Andriole is an Associate Professor of Radiology at Harvard Medical School, Brigham and Women’s Hospital, and is currently the Director of Research Strategy and Operations at the MGH & BWH Center for Clinical Data Science (CCDS) (https://clindatsci.com). She is the Senior Scientist for Education for the ACR Data Science Institute.
Chief Digital Health Officer, Mass General Brigham
Alistair Erskine, MD
Dr. Erskine is responsible for sequencing innovative technologies, harmonizing data across the clinical care, research and health plan enterprise, and activating patients in a manner congruent with emerging patient consumerism. Dr. Erskine heads Mass General Brigham’s e-Care Division with over 400 application and clinical staff.
Chief Innovation Officer, Mass General Brigham
Chris Coburn
Mr. Coburn leads a team of more than 125 tasked with the worldwide commercial application of the unique capabilities and discoveries of all Mass General Brigham’ 74,000 employees. His unit’s business development responsibilities include investing, company creation, international consulting, innovation management, industry collaborations, and licensing. Commercialization revenue exceeds $130 million annually and more than 225 companies have been spun-off from Mass General Brigham in the last decade.
Founder & Executive Director, MESH Incubator
Clinician-in-Residence, MGB Innovation
Marc Succi, MD
Dr. Succi is the Founder and Executive Director of the MESH Incubator and its subsidiary programs, including Network and Core. He is a successful inventor with patents licensed to public biotechnology companies, entrepreneur, active CEO, and is a full-time Radiologist in the MGH ER.
Managing Director, Licensing, Mass General Brigham Innovation
Rebecca Listfield, PhD
Rebecca is the Managing Director of Licensing at Mass General Brigham Innovation. In her role, Rebecca has responsibility for leading the Licensing team in the commercialization of technology developed by clinicians and researchers at Mass General Brigham. Prior to joining Innovation in 2013, Rebecca was a project manager in the Medical Device group at Global Prior Art, Inc., an intellectual property search and analysis firm in Boston, MA. Rebecca earned her BS from Smith College and her PhD from the Harvard-MIT Division of Health Sciences and Technology, where she was awarded a Graduate Research Fellowship from the National Science Foundation. Rebecca is a registered patent agent with the United States Patent and Trademark Office.
Market Sector Leader, Mass General Brigham Innovation
Seema Basu, PhD
As Market Sector Leader, Dr. Basu directs the strategy for open innovation and strategic research collaborations. She leads a team responsible for enabling strategic corporate alliances and new initiatives, such as the Innovation Fellows Program for career development and collaboration with industry. The team also manages licensing and partnering of IP portfolios from Regenerative Medicine, Ragon Institute of MGH, MIT and Harvard, and MGH Center for Global Health.
Associate Director, Licensing, Mass General Brigham Innovation
Nimra Taqi
Dr. Taqi is responsible for managing and licensing technologies on behalf of BWH and MGH arising from the Departments of Surgery and Biomedical Engineering. Prior to joining Partners, Nimra was at Global Prior Art, Inc, an intellectual property research firm in Boston, where she led the Medical Device Group. Dr.
President, Massachusetts Medical Society
David Rosman, MD MBA
Dr. Rosman is a Staff Radiologist in the Division of Abdominal and Interventional Radiology at MGH. He is an Instructor in Radiology at Harvard Medical School. Dr. Rosman is the Medical Director of Mass General Imaging in Worcester and Associate Director of Business Development. He is a board certified radiologist and holds an AU Certification in Nuclear Medicine by the ABR.
Director, IP,
Mass General Brigham Innovation
Bruce Tedeschi, PhD
Bruce is responsible for the management of the Intellectual Property portfolio at Innovation. He also directs an Intern Training Program for Scientists who want to change careers to Patent Law and/or Technology Commercialization. He was formerly an Associate Professor of Neuroscience at Eastern Virginia Medical School and then Patent Examiner at the United States Patent & Trademark Office. Immediately prior to joining Mass General Brigham, he had been in Private Practice as an IP Attorney for several years. He received his PhD from Yale University and his JD from Georgetown University Law Center.
Head of Therapeutics and Operating Partner, Translational Innovation Fund (TIF)
Dione Kobayashi
Dione Kobayashi is Head of Therapeutics and Operating Partner with the Translational Innovation Fund (TIF). Previously, she was Vice President of Preclinical Translation at Cydan Development where she managed diligence opportunities, led scientific projects, and operated companies before to advancing them to Series A launch. Prior to Cydan, Dione held roles as a Director at the neurodegeneration startups Alector and Annexon, and the venture philanthropy-oriented Spinal Muscular Atrophy Foundation. Dione spent a decade working as a scientist and research program leader at Genentech, Elan, and Pfizer across a range of prevalent and rare nervous system indications. Dione received an undergraduate degree from MIT, a master’s degree from the University of Hawai’i at Mānoa, and her Ph.D. in neuroscience from the University of Edinburgh. Dione has launched or cofounded multiple companies in the CNS, gene therapy, and rare disease space, and has raised fund for seeds, Series A, and a Fund. Dione is an Advisor or Investment Committee member to AllStripes, the Bluefield Project, CureCMD, the Lydian Accelerator, MavenView, the Muscular Dystrophy Association, NF2 BioSolutions, and Pivotal BioVenture Partners.
Partner,
Mass General Brigham Ventures
Carl Berke, PhD
Carl’s career has spanned over 25 years in the practice and management of innovation to bring new technologies from lab to market. As a bench scientist and R&D director, he worked at Polaroid Corporation and Hygeia Sciences in the development of photographic and clinical products for both consumer and professional markets – he is an inventor on 6 US patents. He served as a Partner at Integral/Analysis Group, a consulting firm focusing on the management of innovation and growth strategy for clients in healthcare and consumer products. He has been an active private equity investor as a member of Angel Healthcare Investors LLC and is a founder of Mass Medical Angels. He has served on the boards of Quosa [research literature management software], Kasalis [robotics], Combinent [women’s health], Infobionic [cardiac monitoring], Annovation [anesthestic agent] and currently sits on the board of Syntimmune [immunotherapy], QPID Health [bioinformatics], LifeImage [diagnostic image sharing], Sebacia [dermatology therapy] and the Sudanese Education Fund [philanthropy]. Carl holds an AB degree from Cornell University and received his PhD in Organic Chemistry from the University of California at Berkeley. He also holds an appointment as Lecturer in the MIT Sloan School of Management teaching various courses on the topic of biomedical enterprise.
Director, Transactional Affairs Group, Mass GeneralBrigham Innovation
Chris Beares
As Associate Director Chris is responsible for the Transactional Affairs Group. In this role he manages a team of attorneys focused on the negotiation of material transfer agreements, human tissue transfer agreements, confidential disclosure agreements and data use agreements amongst others. In addition to working for Innovation, Chris maintains a private law practice. Chris holds a JD from New England School of Law, a BA in French and a BS in Nursing from The Pennsylvania State University. Chris’ bar admissions include the Massachusetts bar, United States District Court, District of Massachusetts and United States Court of Appeals, First Circuit.